Mycobacterium tuberculosis upregulates coreceptors CCR5 and CXCR4 while HIV modulates CD14 favoring concurrent infection

AIDS Research and Human Retroviruses

Volumn 22, Issue 1, 2006, Pages 45-51

  Rosas Taraco, Adrián G ^a   Arce Mendoza, Alma Y ^a   Caballero Olín, Guillermo ^b   Salinas Carmona, Mario C ^a,c  

^a Facultad de Medicina   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; CD14 ANTIGEN; CD40 ANTIGEN; CELL PROTEIN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN P 15095; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPID; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MACROPHAGE; MEXICO; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; VIRUS PATHOGENESIS; VOLUNTEER;

ANTIGENS, CD14; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HUMANS; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTIONS; RANTES; RECEPTORS, CCR5; RECEPTORS, CXCR4; TUBERCULOSIS; UP-REGULATION;

EID: 32044464267     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.45     Document Type: Article

References (45)

1. Law K, Weiden M, Harkin T, Tchou-Wong K, Chi C, and Rom W: Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am J Respir Crit Care Med 1996;153:799-804.
2. http://www.unaids.org/bangkok2004/report.html.
3. Biswas P, Mantelli B, Delfanti F, et al.: Tumor necrosis factor-alpha drives HIV-1 replication in U937 cell clones and up regulates CXCR4. Cytokine 2001;13:55-59.
4. Fauci A: Host factors and the pathogenesis of HIV-induced disease. Nature 1996;384:529-534.
5. Berger E, Doms R, Fenyö E, et al.: A new classification for HIV-1. Nature 1998;391:240.
6. Zhang L, Huang Y, He T, Cao Y, and Ho D: HIV-1 subtype and second-receptor use. Nature 1996;383:768.
7. Ernst JD: MINIREVIEW: Macrophage receptors for Mycobacterium tuberculosis. Infect Immun 1998;66:1277-1281.
8. Tailleux L, Schwartz O, Herrmann JL, et al.: DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 2003;197:121-127.
9. Schorey JS, Carroll MC, and Brown EJ: A Macrophage invasion mechanism of pathogenic mycobacteria. Science 1997;277:1091-1093.
10. Zaffran Y, Zhang L, and Ellner JJ: Role of CR4 in Mycobacterium tuberculosis-human macrophages binding and signal transduction in absence of serum. Infect Immun 1998;66:4541-4544.
11. Bernardo J, Billingslea A, Blumenthal R, Seetoo K, Simons E, and Fenton M: Differential responses of human mononuclear phagocytes to mycobacterial lipoarabinomannans: Role of CD14 and the mannose receptor. Infect Immun 1998;66:28-35.
12. Foy TM, Aruffo A, Bajorath J, Buhlmann J, and Noelle R: Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 1996;14(1):591-617.
13. Wang Y, Kelly C, Karttunen J, et al.: CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines. Immunity 2001;15:971-983.
14. Chensue SW: Molecular machinations: Chemokine signals in hostpathogen interactions. Clin Microbiol Rev 2001;14:821-835.
15. Sadek M, Sada E, Toosi Z, Schwander S, and Rich A: Chemokines induces by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am J Res Cell Mol Biol 1998;19:513-521.
16. Bradford MM: A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
17. Dubois M, Gilles KA, Hamilton JK, et al.: Colorimetric method for determination of sugar and related substances. Anal Chem 1956;28:350-356.
18. Beck JM, Rosen MJ, and Peavy HH: Pulmonary complications of HIV infection. Am J Respir Crit Care Med 2001;164:2120-2126.
19. Wahl S, Wild T, Peng G, Donze H, and Orenstein J: Co-infection with opportunistic pathogens promotes human immunodeficiency virus type 1 infection in macrophages. J Infect Dis 1999;179:S457-S460.
20. Castro KG: Tuberculosis as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis 1995;21:S66-71.
21. Di Perri G, Cruciani M, Danzi MC, et al.: Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet 1989;2:1502-1504.
22. Daley CL, Small PM, Schecter GF, et al.: An outbreak of tuberculosis with accelerated progression among persons infected with human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992;326:231-235.
23. Couldwell DL, Dore GJ, Harkness JL, et al.: Nosocomial outbreak of tuberculosis in an outpatient HIV treatment room. AIDS 1996;10:521-525.
24. Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, and Schoenbaum EE: High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA 1992;268:504-509.
25. Berning SE, Huitt GA, Iseman MD, and Peloquin CA: Malabsorption of anti-tuberculosis medications by a patients with AIDS. N Engl J Med 1992;327:1817-1818 (Letter).
26. Toosi Z, Mayanja-Kizza H, Hirsch CS, et al.: Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clin Exp Immunol 2001;123:233-238.
27. Savedra R, Delude R, Ingalls R, Fenton M, and Golenbock D: Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signaling system. J Immunol 1996;157:2549-2554.
28. + patients with tuberculosis in Africa: Prolonged elevation during anti-tuberculosis treatment. Clin Exp Immunol 2000;120:483-487.
29. Barr TA and Heath AW: Enhanced in vivo immune responses to bacterial lipopolysaccharide by exogenous CD40 stimulation. Infect Immun 1999;67:3637-3640.
30. Larkin R, Benjamin C, Hsu Y, Li Q, Zukoski L, and Silver R: CD40 Ligand (CD154) does not contribute to lymphocyte-mediated inhibition of virulent Mycobacterium tuberculosis within human monocytes. Infect Immun 2002;70:4716-4720.
31. Cho M, Lee M, Carney M, Berson J, Doms R, and Martin M: Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4. J Virol 1998;72:2509-2515.
32. Dittmar M, Aine M, Graham S, Clapham P, Weiss R, and Simmonds P: HIV-1 tropism and co-receptor use. Nature 1997;385:495-496.
33. Zhang L, Huang Y, He T, Cao Y, and Ho D: HIV-1 subtype and second-receptor use. Nature 1996;383:768.
34. Humphreys TL, Schnizlein-Bick CT, KatzL BP, et al.: Evolution of the cutaneous immune response to experimental Haemophilus ducreyi infection and its relevance to HIV-1 acquisition. J Immunol 2002;169:6316-6323.
35. Juffermans NP, Paxton W. Dekkers P, et al.: Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4+ T cells during human endotoxemia and after stimulation with (myco) bacterial antigens: The role of cytokines. Blood 2000;96:2649-2654.
36. Wahl S, Wild T, Peng G, et al.: Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression. Proc Natl Acad Sci USA 1998;95:12574-12579.
37. Morris L, Cilliers T, Bredell H, Phoswa M, and Martin DJ: CCR5 is the major coreceptor used by HIV-1 subtype C isolates from patients with active tuberculosis. AIDS Res Hum Retroviruses 2001;17:697-701.
38. Juffermans NP, Speelman P, Verbon A, et al.: Patients with active tuberculosis have increased expression of HIV coreceptors CXCR4 and CCR5 on CD4+ T cells. Clin Infect Dis 2001;32:650-652.
39. Hoshino Y, Tse DB, Rochford G, et al.: Mycobacterium tuberculosis-induced CXCR4 and chemokine expression leads to preferential X4 HIV-1 replication in human macrophages. J Immunol 2004;172:6251-6258.
40. Mayaja-Kizza H, Wajja A, Wu M, et al.: Activation of β-chemokines and CCR5 in persons infected with human immunodeficiency virus type-1 and tuberculosis. J Infect Dis 2001;183:1801-1804.
41. Flesch IE and Kaufmann SH: Role of cytokines in tuberculosis. Immunobiology 1993;189:316-339.
42. Flynn J and Chan J: Immunology of tuberculosis. Annu Rev Immunol 2001;19:93-129.
43. Bergeron A, Bonay M, Kambouchner M, et al.: Cytokine patterns in tuberculosis and sarcoid granulomas: Correlations with histopathologic features of the granulomatous response. J Immunol 1997;159:3034-3043.
44. Somoskovi A, Zissel G, Zipfel PF, et al.: Different cytokine patterns correlate with the extension of disease in pulmonary tuberculosis. Eur Cytokine Newt 1999;10:132-142.
45. Kurashima K, Mukaida N, Fujimura M, et al.: Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am J Respir Crit Care Med 1997;159:1474-1477.